{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:14:02Z","timestamp":1760058842727,"version":"build-2065373602"},"reference-count":34,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>First-line treatment for Attention-Deficit\/Hyperactivity Disorder (ADHD) is pharmacological but is associated with poor success rates in adults. The potential to discontinuously use stimulants may confound adherence assessment. Approximately 30\u201350% of adults with ADHD will experience depressive episodes, and associated treatment with antidepressants is generally recommended. It can therefore be expected that patients with a formal F90 diagnosis would show higher medication adherence than patients without a diagnosis and that the simultaneous use of antidepressants would increase adherence to ADHD medication. The primary aim was to explore the influence of factors of ADHD diagnosis and comorbid antidepressant use on stimulant adherence. A retrospective, longitudinal pharmacoepidemiological study was conducted on South African community pharmacy dispensing records for 2012\u20132016 for all patients aged between 18 and 40 years with any record of receiving a drug classified as \u201cCentral nervous system other\u201d by the MIMS in 2015. Patients endorsed with an ADHD-linked diagnostic code (F90) were identified and contrasted with those receiving ADHD-indicated medication in the absence of a confirmatory diagnostic code. Two methods were applied to assess adherence to ADHD and\/or depression treatment drugs: monthly medicine plotting and Proportion of Days Covered (PDC). Patients were classified as being more or less adherent based on monthly medicine plotting criteria. A study population of 89 patients was identified: 50 had F90 diagnostic codes and 39 were classified as \u201cNon F90\u201d. Adherence as measured based on PDC was generally higher for antidepressant use than for methylphenidate for patients classified as being more adherent. A trend towards higher consumption of antidepressants was shown for the treatment-adherent group. Diagnostic code distinction revealed significantly higher adherence rates to methylphenidate for F90 code patients. Adherence rates to antidepressants appeared to be generally higher for non-F90 patients. Many factors may influence adherence to ADHD-indicated drugs; however, the impact of a confirmed diagnosis may be a strong determinant of motivation to be adherent to ADHD pharmacotherapy.<\/jats:p>","DOI":"10.3390\/ijerph22050716","type":"journal-article","created":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T20:42:37Z","timestamp":1746391357000},"page":"716","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Assessment of Potential Factors Influencing Attention-Deficit\/Hyperactivity Disorder Drug Adherence: A Database Study"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6527-0306","authenticated-orcid":false,"given":"Ilse","family":"Truter","sequence":"first","affiliation":[{"name":"Drug Utilization Research Unit (DURU), Department of Pharmacy, Faculty of Health Sciences, Nelson Mandela University, P.O. Box 77000, Gqeberha 6031, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2028-9863","authenticated-orcid":false,"given":"Judith","family":"Regnart","sequence":"additional","affiliation":[{"name":"Drug Utilization Research Unit (DURU), Department of Pharmacy, Faculty of Health Sciences, Nelson Mandela University, P.O. Box 77000, Gqeberha 6031, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anneke","family":"Meyer","sequence":"additional","affiliation":[{"name":"Drug Utilization Research Unit (DURU), Department of Pharmacy, Faculty of Health Sciences, Nelson Mandela University, P.O. Box 77000, Gqeberha 6031, South Africa"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_2","unstructured":"National Collaborating Centre for Mental Health (2009). National Clinical Practice Guideline Number 72\u2014Attention Deficit Hyperactivity Disorder: Diagnosis and Management of ADHD in Children, Young People and Adults, The British Psychological Society and the Royal College of Psychiatrists."},{"key":"ref_3","first-page":"16","article-title":"Neuropsychiatric Attention Deficit and Hyperactivity Disorder that responds to ADHD medication (NADHDM) in the International Classification of Diseases ICD-11: An opportunity to increase sensitivity and specificity of diagnosis","volume":"1","author":"Beckmann","year":"2014","journal-title":"IJHSSE"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.12740\/PP\/69660","article-title":"Mental and behavioural disorders in the ICD-11: Concepts, methodologies, and current status","volume":"51","author":"Gaebel","year":"2017","journal-title":"Psychiatr. Pol."},{"key":"ref_5","first-page":"1543","article-title":"Adherence, persistence, and medication discontinuation in patients with attention-deficit\/hyperactivity disorder\u2014A systematic literature review","volume":"10","author":"Gajria","year":"2014","journal-title":"Neuropsych. Dis. Treat."},{"key":"ref_6","first-page":"S53","article-title":"Resistance and resolutions in adult attention deficit hyperactivity disorder","volume":"23","author":"Semerci","year":"2013","journal-title":"Klinik. Psikofarmakol. B\u00fclteni."},{"key":"ref_7","unstructured":"Rossiter, D. (2016). South African Medicines Formulary (SAMF), Health and Medical Publishing Group. [12th ed.]."},{"key":"ref_8","first-page":"12","article-title":"The management of attention deficit-hyperactivity disorder in children","volume":"79","author":"Schellack","year":"2012","journal-title":"S. Afr. Pharm. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1037\/0278-6133.23.2.207","article-title":"Social support and patient adherence to medical treatment: A meta-analysis","volume":"23","author":"DiMatteo","year":"2004","journal-title":"Health Psychol."},{"key":"ref_10","unstructured":"Horne, R., Weinman, J., Barber, N., Elliott, R.A., and Morgan, M. (2005). Concordance, Adherence and Compliance in Medicine Taking, NCCSDO."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0022-3999(99)00057-4","article-title":"Patients\u2019 beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness","volume":"47","author":"Horne","year":"1999","journal-title":"J. Psychosom. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/MLR.0b013e31819a5acc","article-title":"Physician communication and patient adherence to treatment: A meta-analysis","volume":"47","author":"Zolnierek","year":"2009","journal-title":"Med. Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.4065\/mcp.2010.0575","article-title":"Medication adherence: WHO cares?","volume":"86","author":"Brown","year":"2011","journal-title":"Mayo Clin. Proc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_15","unstructured":"Cameron, L.D., and Leventhal, H. (2003). The common-sense model of self-regulation of health and illness. The Self-Regulation of Health and Illness Behaviour, Routledge."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1177\/0963721411429456","article-title":"Patients\u2019 perceptions of their illness: The dynamo of volition in health care","volume":"21","author":"Petrie","year":"2012","journal-title":"Curr. Dir. Psychol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/070674370905401004","article-title":"Comorbidity in adults with attention-deficit hyperactivity disorder","volume":"54","author":"Cumyn","year":"2009","journal-title":"Can. J. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00406-006-1004-4","article-title":"Psychiatric comorbidity in adults with attention-deficit\/hyperactivity disorder (ADHD)","volume":"256","author":"Sobanski","year":"2006","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"ref_19","first-page":"449","article-title":"Antidepressant discontinuation syndrome","volume":"74","author":"Warner","year":"2006","journal-title":"Am. Fam. Physician"},{"key":"ref_20","first-page":"15","article-title":"Medication holidays","volume":"47","author":"Howland","year":"2009","journal-title":"J. Psychosoc. Nurs. Men."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/camh.12156","article-title":"Caught in the eye of the storm: A qualitative study of views and experiences of planned drug holidays from methylphenidate in child and adolescent ADHD treatment","volume":"21","author":"Ibrahim","year":"2016","journal-title":"Child. Adolesc. Ment. Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.2147\/NDT.S155838","article-title":"Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden\u2014A longitudinal population-based register study","volume":"14","author":"Polyzoi","year":"2018","journal-title":"Neuropsych. Dis. Treat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: Terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1345\/aph.1K671","article-title":"Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication","volume":"43","author":"Martin","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1097\/MLR.0b013e31829b1d2a","article-title":"Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases","volume":"51","author":"Raebel","year":"2013","journal-title":"Med. Care"},{"key":"ref_26","unstructured":"Snyman, J.R. (2016). Monthly Index of Medical Specialities (MIMS), MIMS."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1176\/ps.49.2.196","article-title":"Compliance with medication regimens for mental and physical disorders","volume":"49","author":"Cramer","year":"1998","journal-title":"Psychiatr. Serv."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1080\/13548506.2017.1316412","article-title":"\u2018A necessary evil\u2019: Associations with taking medication and their relationship with medication adherence","volume":"22","author":"Kleppe","year":"2017","journal-title":"Psychol. Health Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00787-016-0919-1","article-title":"Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder","volume":"26","author":"Emilsson","year":"2017","journal-title":"Eur. Child. Adolesc. Psychiatry"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Ciraulo, D.A., and Shader, R.I. (2011). Clinical pharmacology and therapeutics of antidepressants. Pharmacotherapy of Depression, Humana Press.","DOI":"10.1007\/978-1-60327-435-7"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1087054706292165","article-title":"Medication adherence in psychopharmacologically treated adults with ADHD","volume":"10","author":"Safren","year":"2007","journal-title":"J. Atten. Disord."},{"key":"ref_32","unstructured":"(2017). Medicines Related Substances Act 101 of 1965, Section 22A. 6(g, i)."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/2045125317734977","article-title":"Treatment of adult ADHD: A clinical perspective","volume":"8","author":"Geffen","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Hosseinnia, M., Pirzadeh, A., Nazari, A., and Heidari, Z. (2025). Applications for the management of Attention Deficit Hyperactivity Disorder: A systematic review. Front. Public. Health, 13.","DOI":"10.3389\/fpubh.2025.1483923"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/5\/716\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:25:55Z","timestamp":1760030755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/22\/5\/716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,1]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["ijerph22050716"],"URL":"https:\/\/doi.org\/10.3390\/ijerph22050716","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2025,5,1]]}}}